Trial intelligence / Profile preview

Cisplatin + Temozolomide in Pediatric Malignant Gliomas

NCT00360945Phase 2Unknown

Sponsor
Children's Cancer and Leukaemia Group
Start
Apr 2004
Modality
Small Molecules
Countries
3
01

Overview

A Phase 2 trial of cisplatin, temozolomide in malignant glioma, sponsored by Children's Cancer and Leukaemia Group. Status: unknown.

02

Drugs

cisplatintemozolomide
03

Conditions

malignant glioma

Beyond the preview

Go deeper on NCT00360945.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00360945.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call